可能因为您的浏览器不支持样式,您可以更新您的浏览器到最新版本,以获取对此功能的支持,访问下面的网站,获取关于浏览器的信息:
[1]Yamaguchi T.Optimal intensity of warfarin therapy for secondary prevention of stroke in patients with nonvalvular atrial fibrillation: a multicenter, prospective, randomized trial. Japanese Nonvalvular Atrial Fibrillation-Embolism Secondary Prevention Cooperative Study Group[J].Stroke, 2010,31(236):817-821.[2]孙红蕾,徐亮,关海森,等.房颤并发脑栓塞32例临床分析[J].中国实用神经疾病杂志,2007,10(8):57-58.[3]赵秀敏.房颤致脑栓塞60例临床分析[J].中国实用神经疾病杂志,2006, 9(4):100-101.[4]Antithrombotic Trialists′Collaboration.Collaborative meta-analysis of randomized trials of antiplatelet therapy for prevention of death.myocardial infarction,and stroke in high risk patients[J].BMJ,2002,324(7329):71-86.[5]于忠.2009年欧洲心脏病学会IESCJ参会报道[J].心脑血管病防治,2009,9(6):421-421.[6]Ezekowitz MD, Levine JA.Preventing stroke in patients with atrial fibrillation[J].JAMA,1999,281(113):1830-1835.[7]Li C,Xu Q.Mechanical stress-initiated signal transduction in vascular in smooth muscle cells in vitro and in vivo[J]. Cell Signal,2007,19(310):881.[8]Zheng L,Sun Z,Li J,et al.Pulse pressure and mean arterial pressure in relation to ischemic stroke among patients with uncontrolled hypertension in rural of China[J].Stroke,2008,39(98):1932.[9]Hurn PD,Brass LM.Estrogenand and strok:A balance analysis[J].Stroke,2003,34(563):338-341.[10]Kalita J,Kumar G,Bansal V,et al.Relationship of homocysteine with other risk factors and outcome of ischemic stroke[J].Clin Neurol Neurosurg, 2009,111(731):364-367.[11]Sacco RL.Risk factors for TIA and TIA as a risk factor for stroke[J].Neurology,2004,62(1):7-11.[12]黄从新,马长生,杨延宗,等.心房颤动:目前的认识和治疗建议(二)[J].中华心律失常学杂志,2009,10(6):167-197.